Small-Bowel Length and the Dose of Cyclosporine in Children after Liver Transplantation
Open Access
- 15 March 1990
- journal article
- research article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 322 (11), 733-738
- https://doi.org/10.1056/nejm199003153221105
Abstract
Children, particularly infants, require large oral doses of cyclosporine to achieve immunosuppression after liver transplantation. In 53 children who had received liver transplants, we examined the relation of height, weight, residual small-bowel length, and (in 17 children) the terminal plasma clearance rate of cyclosporine to the dose of cyclosporine required to achieve blood levels of 200 ng per milliliter.This publication has 10 references indexed in Scilit:
- The effect of biliary enteroenterostomy on the pharmacokinetics of enterally administered cyclosporine in rats†Hepatology, 1989
- Evaluation of the Pediatric Patient for Liver TransplantationPediatrics, 1986
- Clinical Pharmacokinetics of CyclosporinClinical Pharmacokinetics, 1986
- INDIVIDUALIZATION OF CYCLOSPORINE THERAPY USING PHARMACOKINETIC AND PHARMACODYNAMIC PARAMETERSTransplantation, 1985
- Improved liquid-chromatographic determination of cyclosporine, with concomitant detection of a cell-bound metabolite.Clinical Chemistry, 1985
- Evolution of Liver TransplantationHepatology, 1982
- Geometric method for measuring body surface area: A height-weight formula validated in infants, children, and adultsThe Journal of Pediatrics, 1978
- CLINICAL CALORIMETRYArchives of Internal Medicine, 1916